CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2018 - 2020
Market Capitalization	15,328	13,413	22,447	-	-	-	Upgrade
Market Cap Growth	-40.24%	-40.24%	-	-	-	-	Upgrade
Enterprise Value	15,125	11,820	19,887	-	-	-	Upgrade
Last Close Price	97.68	85.48	143.05	-	-	-	Upgrade
PE Ratio	41.92	36.67	-	-	-	-	Upgrade
Forward PE	27.59	25.45	40.80	-	-	-	Upgrade
PS Ratio	1.94	1.70	5.32	-	-	-	Upgrade
PB Ratio	1.96	1.71	3.00	-	-	-	Upgrade
P/TBV Ratio	2.88	2.52	3.51	-	-	-	Upgrade
PEG Ratio	-	0.31	0.31	-	-	-	Upgrade
EV/Sales Ratio	1.91	1.49	4.71	-	-	-	Upgrade
EV/EBITDA Ratio	34.05	26.61	346.46	-	-	-	Upgrade
EV/EBIT Ratio	111.81	87.38	717.94	-	-	-	Upgrade
Debt / Equity Ratio	0.10	0.10	0.11	1.05	0.62	0.50	Upgrade
Debt / EBITDA Ratio	1.77	1.77	7.64	6.23	-	-	Upgrade
Debt / FCF Ratio	-	-	-	-	-	0.59	Upgrade
Asset Turnover	0.62	0.62	0.45	0.62	0.36	0.17	Upgrade
Quick Ratio	1.29	1.29	2.00	0.89	0.68	0.92	Upgrade
Current Ratio	1.93	1.93	2.33	1.09	0.94	1.10	Upgrade
Return on Equity (ROE)	4.78%	4.78%	-0.98%	5.64%	-27.44%	-70.77%	Upgrade
Return on Assets (ROA)	0.67%	0.67%	0.18%	2.11%	-3.53%	-6.36%	Upgrade
Return on Capital (ROIC)	1.00%	1.00%	0.29%	5.07%	-11.25%	-16.72%	Upgrade
Return on Capital Employed (ROCE)	1.60%	1.60%	0.40%	9.50%	-	-	Upgrade
Earnings Yield	2.39%	2.73%	-0.20%	-	-	-	Upgrade
FCF Yield	-6.19%	-7.08%	-6.44%	-	-	-	Upgrade
Buyback Yield / Dilution	-15.07%	-15.07%	-21.04%	-0.95%	-4.04%	-1.68%	Upgrade

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.